Literature DB >> 11766994

Inhibition of P-selectin specific cell adhesion by a low molecular weight, non-carbohydrate compound, KF38789.

S Ohta1, Y Inujima, M Abe, Y Uosaki, S Sato, I Miki.   

Abstract

OBJECTIVE AND
DESIGN: P-selectin is a cell adhesion molecule of the selectin family. This study evaluated the effects of novel, low molecular weight P-selectin inhibitors in a cell adhesion assay and a murine model of peritonitis. MATERIALS: U937 or HL60 was used for cell adhesion assay. Human polymorphonuclear cells were studied for the production of superoxide. BALB/c mice were used for the in vivo study. TREATMENT: The thioglycollate (TG)-induced accumulation of leukocytes in mice was measured 6 h after the treatment. KF38789 or antibody (1 mg/kg) was injected intravenously prior to TG injection and at 3 h following initial injection.
RESULTS: Low molecular weight, non-carbohydrate inhibitors against P-selectin- mediated cell adhesion were tested. One of the most potent inhibitors, KF38789, inhibited the binding of U937 cells to immobilized P-selectin immunoglobulin G chimeric protein (P-selectin-Ig) with an IC50 value of 1.97 microM. Cell adhesion to both E-selectin-Ig and L-selectin-Ig were not affected even by 100 microM of KF38789. Moreover, KF38789 inhibited P-selectin-induced superoxide production from human polymorphonuclear cells. Intravenously injected KF38789 significantly inhibited the TG-induced accumulation of leukocytes in the mouse peritoneal cavity (p<0.01).
CONCLUSION: A novel low molecular weight compound, KF38789, specifically inhibited P-selectin-dependent cell adhesion and the leukocyte recruitment in mouse peritonitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11766994     DOI: 10.1007/PL00000232

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  8 in total

1.  Non-carbohydrate inhibitors of the lectin DC-SIGN.

Authors:  M Jack Borrok; Laura L Kiessling
Journal:  J Am Chem Soc       Date:  2007-09-29       Impact factor: 15.419

2.  Cannabinoid Receptor-2 Regulates Embryonic Hematopoietic Stem Cell Development via Prostaglandin E2 and P-Selectin Activity.

Authors:  Virginie Esain; Wanda Kwan; Kelli J Carroll; Mauricio Cortes; Sarah Y Liu; Gregory M Frechette; Lea M V Sheward; Sahar Nissim; Wolfram Goessling; Trista E North
Journal:  Stem Cells       Date:  2015-05-26       Impact factor: 6.277

3.  Prostaglandin E2 receptor 4 mediates renal cell carcinoma intravasation and metastasis.

Authors:  Yushan Zhang; Hamsa Thayele Purayil; Joseph B Black; Francis Fetto; Lauren D Lynch; Jude N Masannat; Yehia Daaka
Journal:  Cancer Lett       Date:  2017-01-17       Impact factor: 8.679

4.  A general glycomimetic strategy yields non-carbohydrate inhibitors of DC-SIGN.

Authors:  Kathleen C A Garber; Kittikhun Wangkanont; Erin E Carlson; Laura L Kiessling
Journal:  Chem Commun (Camb)       Date:  2010-08-18       Impact factor: 6.222

5.  Discovery of a potent nanoparticle P-selectin antagonist with anti-inflammatory effects in allergic airway disease.

Authors:  Alison E John; Nicholas W Lukacs; Aaron A Berlin; Aiyappa Palecanda; Robert F Bargatze; Lloyd M Stoolman; Jon O Nagy
Journal:  FASEB J       Date:  2003-10-16       Impact factor: 5.191

6.  P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression.

Authors:  Eilam Yeini; Paula Ofek; Sabina Pozzi; Nitzan Albeck; Dikla Ben-Shushan; Galia Tiram; Sapir Golan; Ron Kleiner; Ron Sheinin; Sahar Israeli Dangoor; Shlomit Reich-Zeliger; Rachel Grossman; Zvi Ram; Henry Brem; Thomas M Hyde; Prerna Magod; Dinorah Friedmann-Morvinski; Asaf Madi; Ronit Satchi-Fainaro
Journal:  Nat Commun       Date:  2021-03-26       Impact factor: 14.919

7.  Synthesis and Characterization of Fucoidan-Chitosan Nanoparticles Targeting P-Selectin for Effective Atherosclerosis Therapy.

Authors:  Mingying Liu; Yu Zhang; Xuewei Ma; Bo Zhang; Yinghui Huang; Jinghong Zhao; Shaobo Wang; Yan Li; Yingguo Zhu; Jiachuan Xiong; Ting He; Yue Wang; Wenhao Han; Ke Yang; Xianjin Bi; Yong Liu; Hao Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-09-09       Impact factor: 7.310

8.  Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome.

Authors:  Shiran Ferber; Galia Tiram; Ana Sousa-Herves; Anat Eldar-Boock; Adva Krivitsky; Anna Scomparin; Eilam Yeini; Paula Ofek; Dikla Ben-Shushan; Laura Isabel Vossen; Kai Licha; Rachel Grossman; Zvi Ram; Jack Henkin; Eytan Ruppin; Noam Auslander; Rainer Haag; Marcelo Calderón; Ronit Satchi-Fainaro
Journal:  Elife       Date:  2017-10-04       Impact factor: 8.140

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.